The American Society of Preventive Oncology has 8 Special Interest Groups (SIGs). Please indicate your interest in being part of these SIGs during the online membership process, when you renew your dues, or by emailing [email protected]
Description of Special Interest Groups:
- Behavioral Science and Health Communication
To understand human behavior using multidisciplinary methods and theories to inform cancer prevention and control efforts, including the design, implementation, evaluation, and dissemination of effective behavioral interventions for risk-promoting behaviors. Additionally, this SIG supports communication research in media, clinical, and public health contexts.
Chair: Carmina Valle, PhD
- Molecular Epidemiology & The Environment
The role of genetics, epigenetics, tumor markers, metabolomics, environmental factors, and individual behaviors and their interplay in cancer prevention, etiology, progression, and outcomes of individuals and populations.
Chair: Elizabeth Hibler, PhD, MPH
- Lifestyle Behaviors, Energy Balance & Chemoprevention
The role of tobacco, nutrition, physical activity, and energy imbalance in cancer causation, progression, and outcomes. It also considers the potential benefits, harms, and risks associated with dietary interventions, exercise regimens, smoking cessation, and chemopreventive agents in reducing cancer risks in the general population or high-risk subsets.
Chair: Marji McCullough, ScD
- Survivorship and Health Outcomes/ Comparative Effectiveness Research
Examining the physical, psychological, social and economic effects of cancer among patients and their families; and the outcomes of particular cancer care practices and interventions, including quality of life as well as mortality. This SIG also brings together scientists seeking to inform clinical decisions by providing evidence on the effectiveness, costs, benefits and harms of different survivorship care options.
Chair: Erin Kent, PhD
- Cancer Health Disparities
Examining the causes of disparities in cancer risk factors and outcomes among population groups. This SIG is also committed to developing and evaluating interventions to reduce and eliminate the unequal burden of cancer.
Chair: Theresa Hastert, PhD
- Early Detection and Risk Prediction of Cancer
Research in screening modalities to enhance the early detection of cancer through imaging, cytology, blood biomarkers, and endoscopy. This SIG also brings together scientists studying the
overall population effectiveness of screening through research on optimal timing and frequency of population-based screening. This SIG is also committed to evaluating new technologies within the context of existing methods through comparing overall effectiveness, coverage, and impact on subsequent diagnosis and treatment. Research also focuses on the use of risk models and other methods to risk stratify to enhance screening efforts.
Chair: Jasmin Tiro, PhD
- Early Career
To bring together junior faculty and pre and postdoctoral fellows focusing on careers in cancer prevention. The purpose of the SIG is to provide educational sessions focused on career development including topics on grant writing and peer review, research and service, finding a job, and developing collaborations and research teams. The SIG sponsors lunches and workshops and networking opportunities.
Chair: Allison Burton-Chase, PhD
- Global Cancer Research
To foster scientific collaborations on global cancer research among ASPO members, and develop connections with US and non-U.S. based researchers to facilitate innovative cancer research projects in international settings. To contribute to the dissemination and implementation of global cancer prevention strategies, and to serve as a resource for ASPO members on global cancer research. To provide guidance to ASPO’s Executive Committee and its SIGs as necessary to better inform discussions related to cancer research in international settings. To support the overall mission of ASPO by supporting the continuous professional development of members involved in global cancer prevention and control, and to facilitate the exchange and translation of scientific information to reduce the cancer burden globally.
Chair: Ramzi Salloum, PhD